Scan to Download
One power score. Smarter investment decisions
SAB Biotherapeutics Inc
SABS2.470USD
-0.320-11.47%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
22.95MMarket Cap
LossP/E TTM
SAB Biotherapeutics Inc
2.470
-0.320-11.47%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total revenue
-100.00%0.00
-100.00%0.00
-62.40%114.70K
-100.00%0.00
207.70%263.14K
62.55%944.58K
-85.88%305.01K
-64.69%1.27M
-98.65%85.52K
-95.08%581.10K
-96.45%2.16M
--3.59M
--6.35M
--11.80M
--60.88M
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
-62.40%114.70K
-100.00%0.00
207.70%263.14K
62.55%944.58K
-85.88%305.01K
-64.69%1.27M
-98.65%85.52K
-95.08%581.10K
-96.45%2.16M
--3.59M
--6.35M
--11.80M
--60.88M
----
----
----
Operating expenses
-6.99%9.67M
-12.73%10.71M
-47.21%10.12M
72.38%11.24M
60.12%10.39M
55.00%12.27M
91.39%19.18M
-42.43%6.52M
-49.38%6.49M
-57.08%7.91M
-86.38%10.02M
3275.34%11.33M
4892.26%12.82M
16420.10%18.44M
--73.57M
--335.55K
--256.85K
--111.61K
R&D expenses
2.70%6.91M
6.25%7.57M
82.34%7.42M
97.03%7.74M
88.56%6.73M
60.39%7.12M
-42.26%4.07M
-45.88%3.93M
-57.93%3.57M
-66.38%4.44M
-87.68%7.04M
--7.26M
--8.48M
--13.21M
--57.18M
----
----
----
Depreciation, depletion, and amortization
-22.11%822.00K
-59.35%822.00K
-28.23%827.60K
-1.89%966.86K
18.17%1.06M
119.03%2.02M
6.30%1.15M
8.27%985.45K
14.31%893.00K
36.27%923.17K
-34.40%1.08M
--910.20K
--781.19K
--677.44K
--1.65M
--0.00
--0.00
----
Other operating expenses
----
----
----
----
----
----
----
----
----
----
86.93%-92.00K
----
----
----
---704.01K
--335.55K
--256.85K
--111.61K
Operating profit
4.58%-9.67M
5.44%-10.71M
46.97%-10.01M
-113.96%-11.24M
-58.15%-10.13M
-54.41%-11.32M
-140.12%-18.87M
32.10%-5.25M
1.02%-6.41M
-10.51%-7.33M
38.06%-7.86M
-2205.55%-7.74M
-2419.77%-6.47M
-5845.01%-6.64M
---12.69M
---335.55K
---256.85K
---111.61K
Net non-operating interest income (expenses)
Non-operating interest income
-96.38%13.56K
-87.45%62.50K
-71.83%136.37K
1829.64%277.17K
1211.11%374.56K
758.61%497.89K
1517.31%484.05K
-17.38%14.36K
80.54%28.57K
630.97%57.99K
29.48%29.93K
493.55%17.39K
446.41%15.82K
227.95%7.93K
--23.11K
--2.93K
--2.90K
--2.42K
Non-operating interest expense
-21.19%129.34K
-6.10%135.56K
-8.99%70.88K
5.97%148.04K
12.16%164.12K
-10.54%144.37K
-11.20%77.88K
-1.36%139.70K
2.87%146.32K
12.06%161.38K
-70.22%87.70K
--141.63K
--142.24K
--144.02K
--294.46K
----
----
----
Special income (expenses)
-128.28%-627.06K
-7.91%5.04M
51.21%-2.31M
-96.55%6.17K
720.10%2.22M
6521.24%5.47M
-13020.42%-4.73M
-77.17%178.76K
-120.66%-357.52K
-98.95%82.59K
100.79%36.59K
43543.37%782.96K
188.80%1.73M
154.66%7.85M
---4.62M
--1.79K
---1.95M
--3.08M
Other non-operating income (expenses)
-19.63%295.63K
15.05%546.63K
153.03%855.00K
676.52%754.65K
--367.83K
--475.13K
948.52%337.91K
6264.31%97.18K
----
----
1269.34%32.23K
--1.53K
----
----
---2.76K
----
----
----
Income before tax
-37.88%-10.11M
-3.40%-5.20M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-191.21%-22.86M
27.89%-5.10M
-41.34%-6.88M
-782.08%-7.35M
55.36%-7.85M
-2038.89%-7.08M
-121.07%-4.87M
-63.74%1.08M
---17.58M
---330.83K
---2.20M
--2.97M
Income tax
----
----
----
----
----
----
-100.00%0.00
----
100.00%0.00
-100.00%0.00
--25.63K
--0.00
---92.28K
--92.28K
----
----
----
----
Income after tax
-37.88%-10.11M
-3.40%-5.20M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-190.26%-22.86M
27.89%-5.10M
-44.07%-6.88M
-845.93%-7.35M
55.22%-7.87M
-2038.89%-7.08M
-116.88%-4.78M
-66.84%985.86K
---17.58M
---330.83K
---2.20M
--2.97M
Net income from continuous operations
-37.88%-10.11M
-3.40%-5.20M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-190.26%-22.86M
27.89%-5.10M
-44.07%-6.88M
-845.93%-7.35M
55.22%-7.87M
-2038.89%-7.08M
-116.88%-4.78M
-66.84%985.86K
---17.58M
---330.83K
---2.20M
--2.97M
Net income attributable to controlling interests
-37.88%-10.11M
-3.40%-5.20M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-190.26%-22.86M
27.89%-5.10M
-44.07%-6.88M
-845.93%-7.35M
55.22%-7.87M
-2038.89%-7.08M
-116.88%-4.78M
-66.84%985.86K
---17.58M
---330.83K
---2.20M
--2.97M
Net income attributable to common shareholders
-37.88%-10.11M
-3.40%-5.20M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-190.26%-22.86M
27.89%-5.10M
-44.07%-6.88M
-845.93%-7.35M
55.22%-7.87M
-2038.89%-7.08M
-116.88%-4.78M
-66.84%985.86K
---17.58M
---330.83K
---2.20M
--2.97M
Basic earnings per share
-37.30%-1.09
-2.85%-0.56
63.73%-1.23
-14.80%-1.12
41.92%-0.79
62.73%-0.54
-93.08%-3.38
40.79%-0.97
-22.87%-1.36
-738.04%-1.46
57.23%-1.75
-635.09%-1.64
25.39%-1.11
-97.28%0.23
---4.09
---0.22
---1.49
--8.42
Diluted earnings per share
-37.30%-1.09
-2.85%-0.56
63.73%-1.23
-14.80%-1.12
41.92%-0.79
62.73%-0.54
-93.08%-3.38
40.79%-0.97
-22.87%-1.36
-738.04%-1.46
57.23%-1.75
-635.09%-1.64
25.39%-1.11
-97.28%0.23
---4.09
---0.22
---1.49
--8.42
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
